APO Research
Talk to an analyst

APO RESEARCH · REPORT

5 Nucleotidase

5 Nucleotidase refers to research coverage of agents targeting 5-prime nucleotidase/CD73 within the selected edition.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The selected edition names investigational agents rather than bulk enzyme supply. Target identity, agent, development stage and study scope are distinct; inclusion is not evidence of approval or treatment efficacy.

What turns activity into demand

Distinguish equipment procurement, recurring materials and any related service within the selected study. Research use, educational use and clinical use have different acceptance requirements and should not be treated as one demand measure.

The commercial boundary

Separate research materials, devices and services within the selected edition. Approvals, labelled use and clinical acceptance need their own evidence; no medical suitability follows from this illustration.

Which supplied scope and interfaces define 5 Nucleotidase?

The selected edition names investigational agents rather than bulk enzyme supply. Target identity, agent, development stage and study scope are distinct; inclusion is not evidence of approval or treatment efficacy.

Technical reading

Selected research

Industry Growth & Trends

Global 5 Nucleotidase Industry Growth and Trends Forecast to 2032

26 December 202591 pages

Choose your research edition.

Industry Research5 Nucleotidase Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal 5 Nucleotidase Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal 5 Nucleotidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 5 Nucleotidase Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal 5 Nucleotidase Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global 5 Nucleotidase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for 5 Nucleotidase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for 5 Nucleotidase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 5 Nucleotidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 5 Nucleotidase include Bristol-Myers Squibb Co, Corvus Pharmaceuticals Inc, Innate Pharma SA, MedImmune LLC and Surface Oncology Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global 5 Nucleotidase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The 5 Nucleotidase market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 5 Nucleotidase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 5 Nucleotidase.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global 5 Nucleotidase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

5 Nucleotidase Market by Company

Bristol-Myers Squibb Co

Corvus Pharmaceuticals Inc

Innate Pharma SA

MedImmune LLC

Surface Oncology Inc

5 Nucleotidase Segment by Type

IPH-53

CPX-006

BMS-986179

AB-680

Others

5 Nucleotidase Segment by Application

Colorectal Cancer

Fallopian Tube Cancer

Gastric Cancer

Metastatic Colorectal Cancer

Others

5 Nucleotidase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 5 Nucleotidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 5 Nucleotidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 5 Nucleotidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 5 Nucleotidase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of 5 Nucleotidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of IPH-53 Table 2. Major Company of CPX-006 Table 3. Major Company of BMS-986179 Table 4. Major Company of AB-680 Table 5. Major Company of Others Table 6. Global 5 Nucleotidase Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global 5 Nucleotidase Sales by Type (2021-2026) & (W Units) Table 8. Global 5 Nucleotidase Sales Market Share in Volume by Type (2021-2026) Table 9. Global 5 Nucleotidase Sales by Type (2021-2026) & (US$ Million) Table 10. Global 5 Nucleotidase Sales Market Share in Value by Type (2021-2026) Table 11. Global 5 Nucleotidase Price by Type (2021-2026) & (US$/Unit) Table 12. Global 5 Nucleotidase Sales by Type (2027-2032) & (W Units) Table 13. Global 5 Nucleotidase Sales Market Share in Volume by Type (2027-2032) Table 14. Global 5 Nucleotidase Sales by Type (2027-2032) & (US$ Million) Table 15. Global 5 Nucleotidase Sales Market Share in Value by Type (2027-2032) Table 16. Global 5 Nucleotidase Price by Type (2027-2032) & (US$/Unit) Table 17. North America 5 Nucleotidase Sales by Type (2021-2026) & (W Units) Table 18. North America 5 Nucleotidase Sales by Type (2021-2026) & (US$ Million) Table 19. Europe 5 Nucleotidase Sales by Type (2021-2026) & (W Units) Table 20. Europe 5 Nucleotidase Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific 5 Nucleotidase Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific 5 Nucleotidase Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America 5 Nucleotidase Sales by Type (2021-2026) & (W Units) Table 24. Latin America 5 Nucleotidase Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa 5 Nucleotidase Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa 5 Nucleotidase Sales by Type (2021-2026) & (US$ Million) Table 27. 5 Nucleotidase Industry Trends Table 28. 5 Nucleotidase Industry Drivers Table 29. 5 Nucleotidase Industry Opportunities and Challenges Table 30. 5 Nucleotidase Industry Restraints Table 31. Global 5 Nucleotidase Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global 5 Nucleotidase Revenue Market Share by Company (2021-2026) Table 33. Global 5 Nucleotidase Sales by Company (2021-2026) & (W Units) Table 34. Global 5 Nucleotidase Sales Share by Company (2021-2026) Table 35. Global 5 Nucleotidase Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global 5 Nucleotidase Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global 5 Nucleotidase Major Company Production Sites and Headquarters Table 38. Global 5 Nucleotidase Company, Product Type & Application Table 39. Global 5 Nucleotidase Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global 5 Nucleotidase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global 5 Nucleotidase Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global 5 Nucleotidase Sales by Region (2021-2026) & (W Units) Table 44. Global 5 Nucleotidase Sales Market Share in Volume by Region (2021-2026) Table 45. Global 5 Nucleotidase Sales by Region (2021-2026) & (US$ Million) Table 46. Global 5 Nucleotidase Sales Market Share in Value by Region (2021-2026) Table 47. Global 5 Nucleotidase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global 5 Nucleotidase Sales by Region (2027-2032) & (W Units) Table 49. Global 5 Nucleotidase Sales Market Share in Volume by Region (2027-2032) Table 50. Global 5 Nucleotidase Sales by Region (2027-2032) & (US$ Million) Table 51. Global 5 Nucleotidase Sales Market Share in Value by Region (2027-2032) Table 52. Global 5 Nucleotidase Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global 5 Nucleotidase Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global 5 Nucleotidase Sales by Application (2021-2026) & (W Units) Table 55. Global 5 Nucleotidase Sales Market Share in Volume by Application (2021-2026) Table 56. Global 5 Nucleotidase Sales by Application (2021-2026) & (US$ Million) Table 57. Global 5 Nucleotidase Sales Market Share in Value by Application (2021-2026) Table 58. Global 5 Nucleotidase Price by Application (2021-2026) & (US$/Unit) Table 59. Global 5 Nucleotidase Sales by Application (2027-2032) & (W Units) Table 60. Global 5 Nucleotidase Sales Market Share in Volume by Application (2027-2032) Table 61. Global 5 Nucleotidase Sales by Application (2027-2032) & (US$ Million) Table 62. Global 5 Nucleotidase Sales Market Share in Value by Application (2027-2032) Table 63. Global 5 Nucleotidase Price by Application (2027-2032) & (US$/Unit) Table 64. North America 5 Nucleotidase Sales by Application (2021-2026) & (W Units) Table 65. North America 5 Nucleotidase Sales by Application (2021-2026) & (US$ Million) Table 66. Europe 5 Nucleotidase Sales by Application (2021-2026) & (W Units) Table 67. Europe 5 Nucleotidase Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific 5 Nucleotidase Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific 5 Nucleotidase Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America 5 Nucleotidase Sales by Application (2021-2026) & (W Units) Table 71. Latin America 5 Nucleotidase Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa 5 Nucleotidase Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa 5 Nucleotidase Sales by Application (2021-2026) & (US$ Million) Table 74. Bristol-Myers Squibb Co Company Information Table 75. Bristol-Myers Squibb Co Business Overview Table 76. Bristol-Myers Squibb Co 5 Nucleotidase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Bristol-Myers Squibb Co 5 Nucleotidase Product Portfolio Table 78. Bristol-Myers Squibb Co Recent Development Table 79. Corvus Pharmaceuticals Inc Company Information Table 80. Corvus Pharmaceuticals Inc Business Overview Table 81. Corvus Pharmaceuticals Inc 5 Nucleotidase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Corvus Pharmaceuticals Inc 5 Nucleotidase Product Portfolio Table 83. Corvus Pharmaceuticals Inc Recent Development Table 84. Innate Pharma SA Company Information Table 85. Innate Pharma SA Business Overview Table 86. Innate Pharma SA 5 Nucleotidase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Innate Pharma SA 5 Nucleotidase Product Portfolio Table 88. Innate Pharma SA Recent Development Table 89. MedImmune LLC Company Information Table 90. MedImmune LLC Business Overview Table 91. MedImmune LLC 5 Nucleotidase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. MedImmune LLC 5 Nucleotidase Product Portfolio Table 93. MedImmune LLC Recent Development Table 94. Surface Oncology Inc Company Information Table 95. Surface Oncology Inc Business Overview Table 96. Surface Oncology Inc 5 Nucleotidase Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Surface Oncology Inc 5 Nucleotidase Product Portfolio Table 98. Surface Oncology Inc Recent Development Table 99. North America 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 100. North America 5 Nucleotidase Sales by Country (2021-2026) & (W Units) Table 101. North America 5 Nucleotidase Sales Market Share by Country (2021-2026) Table 102. North America 5 Nucleotidase Sales Forecast by Country (2027-2032) & (W Units) Table 103. North America 5 Nucleotidase Sales Market Share Forecast by Country (2027-2032) Table 104. North America 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America 5 Nucleotidase Market Size by Country (2021-2026) & (US$ Million) Table 106. North America 5 Nucleotidase Market Share by Country (2021-2026) Table 107. North America 5 Nucleotidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America 5 Nucleotidase Market Share Forecast by Country (2027-2032) Table 109. Europe 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 110. Europe 5 Nucleotidase Sales by Country (2021-2026) & (W Units) Table 111. Europe 5 Nucleotidase Sales Market Share by Country (2021-2026) Table 112. Europe 5 Nucleotidase Sales Forecast by Country (2027-2032) & (W Units) Table 113. Europe 5 Nucleotidase Sales Market Share Forecast by Country (2027-2032) Table 114. Europe 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe 5 Nucleotidase Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe 5 Nucleotidase Market Share by Country (2021-2026) Table 117. Europe 5 Nucleotidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe 5 Nucleotidase Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific 5 Nucleotidase Sales by Country (2021-2026) & (W Units) Table 121. Asia-Pacific 5 Nucleotidase Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific 5 Nucleotidase Sales Forecast by Country (2027-2032) & (W Units) Table 123. Asia-Pacific 5 Nucleotidase Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific 5 Nucleotidase Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific 5 Nucleotidase Market Share by Country (2021-2026) Table 127. Asia-Pacific 5 Nucleotidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific 5 Nucleotidase Market Share Forecast by Country (2027-2032) Table 129. Latin America 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Latin America 5 Nucleotidase Sales by Country (2021-2026) & (W Units) Table 131. Latin America 5 Nucleotidase Sales Market Share by Country (2021-2026) Table 132. Latin America 5 Nucleotidase Sales Forecast by Country (2027-2032) & (W Units) Table 133. Latin America 5 Nucleotidase Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America 5 Nucleotidase Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America 5 Nucleotidase Market Share by Country (2021-2026) Table 137. Latin America 5 Nucleotidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America 5 Nucleotidase Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa 5 Nucleotidase Sales by Country (2021-2026) & (W Units) Table 141. Middle East and Africa 5 Nucleotidase Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa 5 Nucleotidase Sales Forecast by Country (2027-2032) & (W Units) Table 143. Middle East and Africa 5 Nucleotidase Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa 5 Nucleotidase Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa 5 Nucleotidase Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa 5 Nucleotidase Market Share by Country (2021-2026) Table 147. Middle East and Africa 5 Nucleotidase Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa 5 Nucleotidase Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. 5 Nucleotidase Distributors List Table 152. 5 Nucleotidase Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. 5 Nucleotidase Image Figure 2. Global 5 Nucleotidase Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 5 Nucleotidase Market Size (2021-2032) & (US$ Million) Figure 4. Global 5 Nucleotidase Sales (2021-2032) & (W Units) Figure 5. IPH-53 Image Figure 6. Global IPH-53 Sales YoY Growth (2021-2032) & (W Units) Figure 7. CPX-006 Image Figure 8. Global CPX-006 Sales YoY Growth (2021-2032) & (W Units) Figure 9. BMS-986179 Image Figure 10. Global BMS-986179 Sales YoY Growth (2021-2032) & (W Units) Figure 11. AB-680 Image Figure 12. Global AB-680 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global 5 Nucleotidase Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global 5 Nucleotidase Market Share by Type 2025 VS 2032 Figure 17. North America 5 Nucleotidase Sales Market Share in Volume by Type in 2025 Figure 18. North America 5 Nucleotidase Sales Market Share in Value by Type in 2025 Figure 19. Europe 5 Nucleotidase Sales Market Share in Volume by Type in 2025 Figure 20. Europe 5 Nucleotidase Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific 5 Nucleotidase Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific 5 Nucleotidase Sales Market Share in Value by Type in 2025 Figure 23. Latin America 5 Nucleotidase Sales Market Share in Volume by Type in 2025 Figure 24. Latin America 5 Nucleotidase Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa 5 Nucleotidase Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa 5 Nucleotidase Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 5 Nucleotidase Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Colorectal Cancer Image Figure 30. Global Colorectal Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 31. Fallopian Tube Cancer Image Figure 32. Global Fallopian Tube Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 33. Gastric Cancer Image Figure 34. Global Gastric Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 35. Metastatic Colorectal Cancer Image Figure 36. Global Metastatic Colorectal Cancer Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global 5 Nucleotidase Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global 5 Nucleotidase Market Share by Application 2025 VS 2032 Figure 41. North America 5 Nucleotidase Sales Market Share in Volume by Application in 2025 Figure 42. North America 5 Nucleotidase Sales Market Share in Value by Application in 2025 Figure 43. Europe 5 Nucleotidase Sales Market Share in Volume by Application in 2025 Figure 44. Europe 5 Nucleotidase Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific 5 Nucleotidase Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific 5 Nucleotidase Sales Market Share in Value by Application in 2025 Figure 47. Latin America 5 Nucleotidase Sales Market Share in Volume by Application in 2025 Figure 48. Latin America 5 Nucleotidase Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa 5 Nucleotidase Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa 5 Nucleotidase Sales Market Share in Value by Application in 2025 Figure 51. North America 5 Nucleotidase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America 5 Nucleotidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America 5 Nucleotidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America 5 Nucleotidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe 5 Nucleotidase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe 5 Nucleotidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe 5 Nucleotidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe 5 Nucleotidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific 5 Nucleotidase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific 5 Nucleotidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific 5 Nucleotidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific 5 Nucleotidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America 5 Nucleotidase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America 5 Nucleotidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America 5 Nucleotidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America 5 Nucleotidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa 5 Nucleotidase Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa 5 Nucleotidase Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa 5 Nucleotidase Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa 5 Nucleotidase Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. 5 Nucleotidase Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. 5 Nucleotidase Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • IPH-53
  • CPX-006
  • BMS-986179
  • AB-680
  • Others
Applications
  • Colorectal Cancer
  • Fallopian Tube Cancer
  • Gastric Cancer
  • Metastatic Colorectal Cancer
  • Others
Companies covered
  • Bristol-Myers Squibb Co
  • Corvus Pharmaceuticals Inc
  • Innate Pharma SA
  • MedImmune LLC
  • Surface Oncology Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 5 Nucleotidase Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global 5 Nucleotidase Sales Estimates and Forecasts (2021-2032)
  5. 1.3 5 Nucleotidase Market by Type
  6. 1.3.1 IPH-53
  7. 1.3.2 CPX-006
  8. 1.3.3 BMS-986179
  9. 1.3.4 AB-680
  10. 1.3.5 Others
  11. 1.4 Global 5 Nucleotidase Market Size by Type
  12. 1.4.1 Global 5 Nucleotidase Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global 5 Nucleotidase Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global 5 Nucleotidase Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America 5 Nucleotidase Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe 5 Nucleotidase Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific 5 Nucleotidase Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America 5 Nucleotidase Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa 5 Nucleotidase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 5 Nucleotidase Industry Trends
  2. 2.2 5 Nucleotidase Industry Drivers
  3. 2.3 5 Nucleotidase Industry Opportunities and Challenges
  4. 2.4 5 Nucleotidase Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by 5 Nucleotidase Revenue (2021-2026)
  2. 3.2 Global Top Players by 5 Nucleotidase Sales (2021-2026)
  3. 3.3 Global Top Players by 5 Nucleotidase Price (2021-2026)
  4. 3.4 Global 5 Nucleotidase Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 5 Nucleotidase Major Company Production Sites & Headquarters
  6. 3.6 Global 5 Nucleotidase Company, Product Type & Application
  7. 3.7 Global 5 Nucleotidase Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 5 Nucleotidase Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 5 Nucleotidase Players Market Share by Revenue in 2025
  11. 3.8.3 2025 5 Nucleotidase Tier 1, Tier 2, and Tier 3
4 5 Nucleotidase Regional Status and Outlook
  1. 4.1 Global 5 Nucleotidase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global 5 Nucleotidase Historic Market Size by Region
  3. 4.2.1 Global 5 Nucleotidase Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global 5 Nucleotidase Sales in Value by Region (2021-2026)
  5. 4.2.3 Global 5 Nucleotidase Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global 5 Nucleotidase Forecasted Market Size by Region
  7. 4.3.1 Global 5 Nucleotidase Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global 5 Nucleotidase Sales in Value by Region (2027-2032)
  9. 4.3.3 Global 5 Nucleotidase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 5 Nucleotidase by Application
  1. 5.1 5 Nucleotidase Market by Application
  2. 5.1.1 Colorectal Cancer
  3. 5.1.2 Fallopian Tube Cancer
  4. 5.1.3 Gastric Cancer
  5. 5.1.4 Metastatic Colorectal Cancer
  6. 5.1.5 Others
  7. 5.2 Global 5 Nucleotidase Market Size by Application
  8. 5.2.1 Global 5 Nucleotidase Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global 5 Nucleotidase Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global 5 Nucleotidase Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America 5 Nucleotidase Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe 5 Nucleotidase Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific 5 Nucleotidase Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America 5 Nucleotidase Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa 5 Nucleotidase Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb Co
  2. 6.1.1 Bristol-Myers Squibb Co Company Information
  3. 6.1.2 Bristol-Myers Squibb Co Business Overview
  4. 6.1.3 Bristol-Myers Squibb Co 5 Nucleotidase Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Co 5 Nucleotidase Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Co Recent Developments
  7. 6.2 Corvus Pharmaceuticals Inc
  8. 6.2.1 Corvus Pharmaceuticals Inc Company Information
  9. 6.2.2 Corvus Pharmaceuticals Inc Business Overview
  10. 6.2.3 Corvus Pharmaceuticals Inc 5 Nucleotidase Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Corvus Pharmaceuticals Inc 5 Nucleotidase Product Portfolio
  12. 6.2.5 Corvus Pharmaceuticals Inc Recent Developments
  13. 6.3 Innate Pharma SA
  14. 6.3.1 Innate Pharma SA Company Information
  15. 6.3.2 Innate Pharma SA Business Overview
  16. 6.3.3 Innate Pharma SA 5 Nucleotidase Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Innate Pharma SA 5 Nucleotidase Product Portfolio
  18. 6.3.5 Innate Pharma SA Recent Developments
  19. 6.4 MedImmune LLC
  20. 6.4.1 MedImmune LLC Company Information
  21. 6.4.2 MedImmune LLC Business Overview
  22. 6.4.3 MedImmune LLC 5 Nucleotidase Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 MedImmune LLC 5 Nucleotidase Product Portfolio
  24. 6.4.5 MedImmune LLC Recent Developments
  25. 6.5 Surface Oncology Inc
  26. 6.5.1 Surface Oncology Inc Company Information
  27. 6.5.2 Surface Oncology Inc Business Overview
  28. 6.5.3 Surface Oncology Inc 5 Nucleotidase Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Surface Oncology Inc 5 Nucleotidase Product Portfolio
  30. 6.5.5 Surface Oncology Inc Recent Developments
7 North America by Country
  1. 7.1 North America 5 Nucleotidase Sales by Country
  2. 7.1.1 North America 5 Nucleotidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America 5 Nucleotidase Sales by Country (2021-2026)
  4. 7.1.3 North America 5 Nucleotidase Sales Forecast by Country (2027-2032)
  5. 7.2 North America 5 Nucleotidase Market Size by Country
  6. 7.2.1 North America 5 Nucleotidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America 5 Nucleotidase Market Size by Country (2021-2026)
  8. 7.2.3 North America 5 Nucleotidase Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe 5 Nucleotidase Sales by Country
  2. 8.1.1 Europe 5 Nucleotidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe 5 Nucleotidase Sales by Country (2021-2026)
  4. 8.1.3 Europe 5 Nucleotidase Sales Forecast by Country (2027-2032)
  5. 8.2 Europe 5 Nucleotidase Market Size by Country
  6. 8.2.1 Europe 5 Nucleotidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe 5 Nucleotidase Market Size by Country (2021-2026)
  8. 8.2.3 Europe 5 Nucleotidase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific 5 Nucleotidase Sales by Country
  2. 9.1.1 Asia-Pacific 5 Nucleotidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific 5 Nucleotidase Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific 5 Nucleotidase Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific 5 Nucleotidase Market Size by Country
  6. 9.2.1 Asia-Pacific 5 Nucleotidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific 5 Nucleotidase Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific 5 Nucleotidase Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America 5 Nucleotidase Sales by Country
  2. 10.1.1 South America 5 Nucleotidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America 5 Nucleotidase Sales by Country (2021-2026)
  4. 10.1.3 South America 5 Nucleotidase Sales Forecast by Country (2027-2032)
  5. 10.2 South America 5 Nucleotidase Market Size by Country
  6. 10.2.1 South America 5 Nucleotidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America 5 Nucleotidase Market Size by Country (2021-2026)
  8. 10.2.3 South America 5 Nucleotidase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa 5 Nucleotidase Sales by Country
  2. 11.1.1 Middle East and Africa 5 Nucleotidase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa 5 Nucleotidase Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa 5 Nucleotidase Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa 5 Nucleotidase Market Size by Country
  6. 11.2.1 Middle East and Africa 5 Nucleotidase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa 5 Nucleotidase Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa 5 Nucleotidase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 5 Nucleotidase Value Chain Analysis
  2. 12.1.1 5 Nucleotidase Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 5 Nucleotidase Production Mode & Process
  7. 12.2 5 Nucleotidase Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 5 Nucleotidase Distributors
  10. 12.2.3 5 Nucleotidase Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst